ArticleCancer medicine2019

Prognostic factors for overall survival in patients with chronic myeloid leukemia treated with imatinib at the National Cancer Institute - Mexico, from 2000 to 2016.

Jimena Ylescas-Soria et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.